CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients.
López C, Bosch R, Korzynska A, García-Rojo M, Bueno G, García-Fontgivell JF, Martínez González S, Gras Navarro A, Sauras Colón E, Casanova Ribes J, Roszkowiak L, Mata D, Arenas M, Gómez J, Roso A, Berenguer M, Reverté-Villarroya S, Llobera M, Baucells J, Lejeune M.
López C, et al. Among authors: roso a.
Breast Cancer. 2022 Jul;29(4):618-635. doi: 10.1007/s12282-022-01336-2. Epub 2022 Feb 8.
Breast Cancer. 2022.
PMID: 35137329